Form 4 for CLPT ClearPoint Neuro, Inc.
Accepted 2024-02-23 00:00:00 ET · period of report 2024-02-22 · accession 0001285550-24-000018 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-02-23 | 2024-02-22 | CLPT | STIGALL L. JEREMY | GM, Biologics, Drug Delivery | F - Tax | $7.49 | -1,039 | 42.0K | -2% | -$7,782 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-02-22 | F | D | 1,039 | $7.49 | 41,985 | D | — | — | (F1) Represents the amount of shares delivered to satisfy applicable tax withholding obligations in connection with the vesting of shares of restricted stock. |